EODData

MEMBERSHIP REGISTER LOG IN

FRA, HTD: Corcept Therapeutics Incorporated

03 Jul 2026
LAST:

77.44

CHANGE:
 0.54		OPEN:
78.12		HIGH:
78.12		ASK:
0.00		VOLUME:
109
CHG(%):
0.70		PREV:
76.90		LOW:
77.44		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Jul 2678.1278.1277.4477.44109
02 Jul 2676.9076.9076.9076.90296
30 Jun 2676.4476.4476.4476.440
29 Jun 2676.1676.1876.1676.180
25 Jun 2670.9870.9870.9870.980
24 Jun 2669.4469.4469.4469.440
23 Jun 2668.8270.4468.8270.440
22 Jun 2668.9469.4268.9469.420
19 Jun 2668.9869.0468.9468.94727
18 Jun 2670.5870.5869.6469.640

PROFILE

Name:Corcept Therapeutics Incorporated
About:Corcept Therapeutics Incorporated engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous cushing's syndrome; and who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also developing relacorilant, which is in phase III clinical trial for the treatment of hypercortisolism; relacorilant combined with nab-paclitaxel which is in phase III clinical trial to treat platinum-resistant ovarian tumors; treatment for adrenal cancer and cortisol excess which is in phase 1b clinical trial; and for treatment for prostate cancer which is in phase II clinical trial. In addition, it develops dazucorilant, which is in phase II clinical trial for the treatment of amyotrophic lateral sclerosis; and miricorilant, which is in phase IIb trial for the treatment of metabolic dysfunction-associated steatohepatitis. The company was incorporated in 1998 and is headquartered in Redwood City, California.
Sector:Healthcare
Industry:Biotechnology
Address:101 Redwood Shores Parkway, Redwood City, CA, United States, 94065
Website:https://www.corcept.com
ISIN:US2183521028
LEI:529900EO9LUTFMZ7FF90

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:8.36 
Forward P/E:70.51 
PEG Ratio:70.51 
Price to Sales:9.91 
Price to Book:0.96 
Profit Margin:0.14 
Operating Margin:0.05 
Return on Assets:0.05 
Return on Equity:0.17 
EPS Ratio:2.98 
Revenue:628.91M 
EBITDA:57.23M 
Shares:35.43M 
Market Cap:2.744B 

TECHNICAL INDICATORS

MA5:75.592.5%
MA10:72.586.7%
MA20:70.0810.5%
MA50:56.3337.5%
MA100:44.4374.3%
MA200:51.7749.6%
STO9:92.59 
STO14:92.59 
RSI14:77.20 
MTM14:6.22
ROC14:0.09 
ATR:1.44 
Week High:78.120.9%
Week Low:76.161.7%
Month High:78.120.9%
Month Low:60.5649.6%
Year High:78.120.9%
Year Low:27.49181.7%